Dec 7, 2021
Biomarker testing is an important part of precision medicine; however, many commercial health plans and state Medicaid programs lack adequate coverage, which can have life-threatening consequences for patients with cancer who could benefit from biomarker testing.
Some good news: health insurance coverage advocates have...